BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8786745)

  • 21. Yersinia pseudotuberculosis-induced calcium signaling in neutrophils is blocked by the virulence effector YopH.
    Andersson K; Magnusson KE; Majeed M; Stendahl O; Fällman M
    Infect Immun; 1999 May; 67(5):2567-74. PubMed ID: 10225922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular bases for multidrug resistance in Yersinia pseudotuberculosis.
    Cabanel N; Galimand M; Bouchier C; Chesnokova M; Klimov V; Carniel E
    Int J Med Microbiol; 2017 Oct; 307(7):371-381. PubMed ID: 28830739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
    Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
    Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic comparison of Yersinia pestis and Yersinia pseudotuberculosis by combination of suppression subtractive hybridization and DNA microarray.
    Wang X; Zhou D; Qin L; Dai E; Zhang J; Han Y; Guo Z; Song Y; Du Z; Wang J; Wang J; Yang R
    Arch Microbiol; 2006 Aug; 186(2):151-9. PubMed ID: 16832628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some aspects of the immunology of pseudotuberculosis.
    Besednova NN; Somov GP
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(3):235-41. PubMed ID: 6754810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of culture conditions and virulence plasmids on expression of immunoglobulin-binding proteins of Yersinia pseudotuberculosis.
    Naberezhnykh GA; Sidorin EV; Lapshina LA; Reunov AV; Solov'eva TF
    Biochemistry (Mosc); 2006 Nov; 71(11):1284-8. PubMed ID: 17140391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yersinia pseudotuberculosis is resistant to killing by human neutrophils.
    Laws TR; Davey MS; Green C; Cooper IA; Titball RW; Lukaszewski RA
    Microbes Infect; 2011 Jun; 13(6):607-11. PubMed ID: 21354325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypsin-like proteinase and its endogenous inhibitor from Yersinia pseudotuberculosis. Biological activity.
    Burtseva TI; Loenko YN
    Biochemistry (Mosc); 1999 Sep; 64(9):986-9. PubMed ID: 10521713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of plasmid DNA among different serogroups of Yersinia pseudotuberculosis.
    Kaneko S; Maruyama T; Fukushima H
    Contrib Microbiol Immunol; 1991; 12():75-9. PubMed ID: 1935117
    [No Abstract]   [Full Text] [Related]  

  • 30. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
    Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
    Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [PLASMID-ASSOCIATED VIRULENCE OF YERSINIA PSEUDOTUBERCULOSIS AND INFECTIOUS PROCESS].
    Somova LM; Shubin FN; Drobot EI; Plekhova NG; Lyapun IN
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):74-85. PubMed ID: 30695393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
    Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
    EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phagocytic function of neutrophils during dialysis in relation to some immunological findings.
    Ksiazek A; Kozioł M
    Nephrol Dial Transplant; 1991; 6 Suppl 3():31-4. PubMed ID: 1775264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YopK, a novel virulence determinant of Yersinia pseudotuberculosis.
    Holmström A; Rosqvist R; Wolf-Watz H; Forsberg A
    Contrib Microbiol Immunol; 1995; 13():239-43. PubMed ID: 8833843
    [No Abstract]   [Full Text] [Related]  

  • 36. [Various characteristics of Yersinia pseudotuberculosis determined by plasmid 45 Md associated with calcium dependence].
    Shubin FN; Sibirtsev IuT; Rasskazov VA; Bagriantsev VN
    Mol Gen Mikrobiol Virusol; 1986 Oct; (10):26-31. PubMed ID: 3796652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae.
    Pujol C; Bliska JB
    Clin Immunol; 2005 Mar; 114(3):216-26. PubMed ID: 15721832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Virulence of Yersinia pseudotuberculosis strains isolated from environment as a threat to human epidemic].
    Czyzewska I; Furowicz AJ
    Przegl Epidemiol; 2003; 57(2):263-70. PubMed ID: 12910593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of IS285 and IS100 in Yersinia pestis and Yersinia pseudotuberculosis genomes].
    Bobrov AG; Filippov AA
    Mol Gen Mikrobiol Virusol; 1997; (2):36-40. PubMed ID: 9213772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [THe characteristics of the epidemic process of pseudotuberculosis infection in the southern and northwestern foci of Irkutsk Province].
    Chesnokova MV; Klimov VT; Maramovich AS; Lemeshko RA
    Med Parazitol (Mosk); 1995; (4):27-30. PubMed ID: 8587513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.